Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Argus Health
Chubb
Covington
Cerilliant
US Department of Justice
US Army
Deloitte
Mallinckrodt
AstraZeneca

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019887

« Back to Dashboard

NDA 019887 describes NEBUPENT, which is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from one supplier. Additional details are available on the NEBUPENT profile page.

The generic ingredient in NEBUPENT is pentamidine isethionate. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentamidine isethionate profile page.
Summary for 019887
Tradename:NEBUPENT
Applicant:Fresenius Kabi Usa
Ingredient:pentamidine isethionate
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details
Pharmacology for NDA: 019887
Medical Subject Heading (MeSH) Categories for 019887
Suppliers and Packaging for NDA: 019887
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEBUPENT pentamidine isethionate FOR SOLUTION;INHALATION 019887 NDA Fresenius Kabi USA, LLC 63323-877 63323-877-15 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-877-15) > 6 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;INHALATIONStrength300MG/VIAL
Approval Date:Jun 15, 1989TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;INHALATIONStrength600MG/VIAL
Approval Date:Mar 22, 1996TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Deloitte
Daiichi Sankyo
Farmers Insurance
Citi
Federal Trade Commission
Medtronic
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot